ARICEUM THERAPEUTICS
Live / Registered — Registered (as of 05 Mar 2024)
What this means for you
Registered since 05 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79350974
- Registration number
- 7318210
- Mark type
- Stylized text
- Filed
- 22 Aug 2022
- Published for opposition
- 19 Dec 2023
- Registered
- 05 Mar 2024
- Attorney of record
- Molly Buck Richard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of cancer; pharmaceutical drugs for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of cancer; injectable pharmaceuticals for use in the treatment of cancer; chemico-pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and substances for use in the treatment of cancer; pharmaceutical preparations for human use for use in the treatment of cancer; synthetic peptides for pharmaceutical purposes for use in the diagnosis and treatment of cancer; pharmaceutical preparations for medical purposes for use in the treatment of cancer; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; radioactive substances for medical purposes; radioactive materials for medical purposes; radioactive elements for medical use
- Class 042 — Scientific and technological services: Pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; research of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; conducting clinical trials for pharmaceutical products of others; development of pharmaceutical preparations and medicines; research on the subject of pharmaceuticals; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations for treating malignant tumours
Owner
Prosecution history
- 12 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Aug 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2023 — NOTIFICATION PROCESSED BY IB
- 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Dec 2023 — PUBLISHED FOR OPPOSITION
- 29 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Nov 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED